norflurane has been researched along with salmeterol xinafoate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kirby, SM; Smith, J; Ventresca, GP | 1 |
| Ventresca, GP | 1 |
| Jenkins, M | 1 |
3 trial(s) available for norflurane and salmeterol xinafoate
| Article | Year |
|---|---|
Salmeterol inhaler using a non-chlorinated propellant, HFA134a: systemic pharmacodynamic activity in healthy volunteers.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Adult; Aerosol Propellants; Albuterol; Bronchodilator Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Hydrocarbons, Fluorinated; Male; Potassium; Pulse; Salmeterol Xinafoate | 1995 |
Clinical pharmacology of HFA134a.
Topics: Albuterol; Bronchodilator Agents; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Hydrocarbons, Fluorinated; Male; Nebulizers and Vaporizers; Salmeterol Xinafoate | 1995 |
Clinical evaluation of CFC-free metered dose inhalers.
Topics: Adult; Aerosol Propellants; Albuterol; Androstadienes; Anti-Inflammatory Agents; Asthma; Bronchodilator Agents; Child; Cross-Over Studies; Double-Blind Method; Fluticasone; Humans; Hydrocarbons, Fluorinated; Nebulizers and Vaporizers; Peak Expiratory Flow Rate; Salmeterol Xinafoate; Technology, Pharmaceutical | 1995 |